It was almost two years ago that Ian Franks brought you the welcome news that AIMS was a new HSCT charity. Today, he looks further and finds a young but efficient organisation united by a desire to 'put something back'.
HSCT (Autologous Haematopoietic Stem Cell Transplantation) is an effective therapy to fight multiple sclerosis, the level of side effects is acceptable, and the therapy is safe, Ian Franks believes. Now, he answers the question why he has not undergone HSCT himself,
Although I have taken a break from writing during August, I just had to catch up with Paul Morrison who, earlier this month, travelled to Moscow to undergo HSCT for multiple sclerosis. The exact type of the disease is a matter of opinion, his neurologist says Paul has SPMS, but tests in Moscow indicate a … Continue reading Paul pays tribute to dedication of staff as he prepares to leave Moscow HSCT centre
I had planned to take a break from writing this month, August being a slow news month that is well known among journalists as the silly season. That's when minor stories are given major coverage, because of a shortage of stories of real substance. However, I could not let Monday August 6 go unmarked. Why? … Continue reading Paul’s Moscow HSCT for MS journey begins
Former Londoner Paul Morrison is seeking support to travel to Moscow to receive hematopoietic stem cell transplantation (HSCT) in August. These days Paul (46) and his family live a stone’s throw from my home in southern Spain. He shares my challenge of living with multiple sclerosis. His dad, Phil, has set up a GoFundMe account, … Continue reading #paulsfighttowalk : Support sought for HSCT in Moscow
There’s good news for anyone with multiple sclerosis who is considering undergoing HSCT, especially if that involves being treated in Russia. And that’s because Denis Fedorenko, MD, who is in charge of the stem cell transplant program for MS patients, has put together a comprehensive guide to the whole procedure at the A.A. Maximov Department … Continue reading Russian Physician’s Guide to HSCT in Moscow
Phoebe Scopes was the first international patient to receive Hematopoietic Stem Cell Transplantation (HSCT) therapy for multiple sclerosis in Moscow. In this fourth, and last, part of her story, we join Phoebe on her return home to the London. Ian: What is your post-HSCT MS state from getting home until today? Phoebe: Back home, four … Continue reading Phoebe’s HSCT Story: Back home (Last in a Series)